International Biotechnology Trust PLC Esperion Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.81 - $11.92 $45,694 - $113,240	-9,500 Closed	0 $0
Q1 2020 May 18, 2020	SELL	$27.44 - $73.84 $562,520 - $1.51 Million	-20,500 Reduced 68.33%	9,500 $298,000
Q4 2019 May 18, 2020	BUY	$35.4 - $59.82 $35,400 - $59,820	1,000 Added 3.45%	30,000 $1.79 Million
Q3 2018 Nov 13, 2018	BUY	$40.74 - $51.41 $1.18 Million - $1.49 Million	29,000 New	29,000 $1.26 Million
Q2 2018 Aug 13, 2018	SELL	$36.2 - $76.4 $362,000 - $764,000	-10,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $659,400 - $807,600	10,000 New	10,000 $723,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.